Home>>Signaling Pathways>> Obesity, Appetite Control & Diabetes>> Obesity>>Obestatin (rat) (trifluoroacetate salt)

Obestatin (rat) (trifluoroacetate salt)

Catalog No.GC44484

Obestatin is a 23-amino acid peptide hormone that is formed by cleavage of the ghrelin and obestatin prepropeptide.

Products are for research use only. Not for human use. We do not sell to patients.

Obestatin (rat) (trifluoroacetate salt) Chemical Structure

Size Price Stock Qty
500μg
$221.00
In stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Customer Reviews

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Obestatin is a 23-amino acid peptide hormone that is formed by cleavage of the ghrelin and obestatin prepropeptide. It is secreted by rat stomach, brain, perinatal pancreas, myenteric plexus, Leydig cells, and gastrointestinal mucosa and levels are decreased in rat plasma in response to fasting. Total obestatin levels are also reduced in rat fundus and intestine following treadmill exercise training. Obestatin inhibits release of insulin, somatostatin, and pancreatic polypeptide and stimulates glucagon release from mouse and rat pancreatic islets in vitro in a concentration-dependent manner. In vivo, obestatin (320 μg/kg) reduces food intake without affecting growth hormone or corticosterone release in mice. It also inhibits water intake and dehydration-induced vasopressin secretion in response to a hypovolemic challenge in rats.

Reviews

Review for Obestatin (rat) (trifluoroacetate salt)

Average Rating: 5 ★★★★★ (Based on Reviews and 29 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Obestatin (rat) (trifluoroacetate salt)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.